CWRU Center for Excellence on the Impact of Substance Use on HIV
Project Number5P30DA054557-03
Contact PI/Project LeaderLEVINE, ALAN DAVID
Awardee OrganizationCASE WESTERN RESERVE UNIVERSITY
Description
Abstract Text
Project Summary - Overview
The newly developed CWRU (Case Western Reserve University) Center for Excellence on the
Impact of Substance Use on HIV was conceived in August 2017 and was initiated to effectively
promote excellence in basic, translational, and clinical research concerning the intersection between
substance use and HIV. The Center for Excellence includes 12 NIDA-funded Investigators who
collectively hold 9 R01, 2 DP1, 3 R34, 2 R44, 1 U01, and 2 K01 drawn from the CWRU School of
Medicine, University Hospitals Cleveland Medical Center, MetroHealth Medical Center, the Cleveland
Clinic Foundation, the Louis Stokes Cleveland Veterans Administration Medical Center, the CWRU
Mandel School of Applied Social Sciences, the Begun Center for Violence Prevention Research and
Education, and the Cuyahoga County, Lorain County, and City of Cleveland Departments of Health.
Major research strengths in the Center for Excellence include impact of drug use on HIV
immunopathogenesis, HIV latency and Cure, NeuroAIDS, gastrointestinal dysfunction, sexual risk
behavior, and HIV and HCV co-infections. Our studies are anchored by advanced computational,
systems biology, biomimetic models, and induced pluripotent stem cell (iPSC) technologies that
provide the opportunity to perform meta-omics analyses of the impact of opioid, methamphetamine,
cannabis, and cocaine misuse on several clinical, virological, immunological, behavioral, and
neurological outcomes of HIV disease. The Center for Excellence has the following Specific Aims:
• Provide scientific leadership to position the Center at the forefront of substance use
disorder research and function as a national research resource for the study of drug use
in persons with HIV.
• Establish an administrative infrastructure that maintains fiscal and management oversight
of the Cores.
• Apply advanced Computational Biology, Primary Cells, Biomimetic models, and iPSC-
derived Cells to study of the impact of substance use on HIV disease.
• Support translational, clinical, and behavioral research through access to unique clinical
cohorts of persons with substance use disorder with HIV and at risk for HIV.
• Accelerate junior faculty development and encourage experienced faculty to enter the
substance use research arena to support the next generation of investigators.
• Participate in community outreach.
Public Health Relevance Statement
Project Narrative - Overview
Substance misuse remains the second most common mode of exposure to HIV among AIDS
cases nationwide, representing 31% of total diagnoses. In addition, substance use is associated
with a more severe course of HIV disease, as shown by the poor immune reconstitution and an
increased rate of co-morbidities. The Case Western Reserve University (CWRU) Center for
Excellence creates a collaborative environment that strongly supports Substance Use in HIV
research at CWRU and for our colleagues in other NIDA-sponsored Centers nationwide.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAcquired Immunodeficiency SyndromeAffectAwardBasic ScienceBehavioralBehavioral ResearchBioinformaticsBiometryBiomimeticsBrainCannabisCapitalCaringCell modelCellsCitiesClinicClinicalClinical InvestigatorClinical ResearchCocaine misuseCommunitiesCommunity OutreachComplexComputational BiologyCountyDatabasesDevelopmentDiagnosisDisciplineDiseaseDrug usageEducationEquipmentExposure toFacultyFoundationsFunctional disorderFundingGrantHIVHIV/HCVHealthHepatitis C co-infectionHospitalsImmuneImmunologicsImmunosuppressionIndividualInfrastructureInternationalInvestigationLeadershipLinkMedical centerMedicineMemory impairmentMental HealthMentorsMethamphetamineMethodsModelingMolecularMotivationMucous MembraneMyelogenousNational Institute of Drug AbuseNeurocognitive DeficitNeurologicNeurological outcomeOpioidOutcomePathogenesisPatient RecruitmentsPatientsPersonsPhysician ExecutivesPositioning AttributePrevention ResearchPrevention educationProcessProteomicsPublic HealthReportingResearchResearch PersonnelResearch SupportResourcesRiskRuralSchoolsServicesSocial SciencesStrategic PlanningSubstance Use DisorderSurveysSystems BiologyTeacher Professional DevelopmentTechnologyTissuesTranslational ResearchTraumaUnderserved PopulationUnited States Department of Veterans AffairsUniversitiesUniversity HospitalsVictimizationViolencebehavioral health interventionbehavioral outcomebiobankcareerclinical databasecocaine usecohortcollaborative environmentcomorbiditydesignexperiencegastrointestinalimmune reconstitutioninduced pluripotent stem cellinduced pluripotent stem cell technologyinnovationinsightinterdisciplinary collaborationlecturerlipidomicsmarijuana usemedical schoolsmetabolomicsmethamphetamine usemicrobiomeneuroAIDSneuroinflammationnew technologynext generationopioid useprogramsservice interventionsexual risk behaviorstem cellssubstance misusesubstance usesuburbsymposiumsynergismthree-dimensional modelingtranscriptomicsviolence prevention
No Sub Projects information available for 5P30DA054557-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P30DA054557-03
Patents
No Patents information available for 5P30DA054557-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P30DA054557-03
Clinical Studies
No Clinical Studies information available for 5P30DA054557-03
News and More
Related News Releases
No news release information available for 5P30DA054557-03
History
No Historical information available for 5P30DA054557-03
Similar Projects
No Similar Projects information available for 5P30DA054557-03